Healthcare Industry Business Outlook and Procurement Report July 2018 – December 2018

Pages: 50 Published: August 31, 2018 Report Code: HC6900PR

GlobalData’s "Healthcare Industry Business Outlook and Procurement Report July 2018 – December 2018", examines executives’ opinions on the business outlook and procurement activities over July-December 2018. Organizations can know about key business priorities, changes in capital expenditure, global revenue contributors, and key information about the organizations’ digital transformation strategies along with investment in emerging technologies. Additionally, it provides information categorized by region and company types.

The highest percentages of healthcare industry executives identify expansion in the current market and new product development as the foremost priorities of healthcare enterprises over the next six months. Moreover, increasing and aging populations, advancement in medical equipment and treatments, major public health problems, and continuous development of innovative drugs and devices are factors expected to drive market expansion and expenditure in the global healthcare industry. Furthermore, the US and China are the leading developed and emerging markets, respectively, that are expected to offer significant growth prospects to the healthcare industry. While companies are facing critical challenges such as regulatory changes, rising competition, and pricing pressure, 61% of respondents anticipate a rise in M&A activities over the next six months. Additionally, executives identified that process equipment and clinical trials share the highest proportion of spend within the companies’ procurement budget. The survey also reveals that artificial intelligence, and APIs and digital platforms are the key emerging technologies that are expected to gain investment in the healthcare industry over the next two years.

What else does this report offer?

– Key business priorities: examines the healthcare companies’ important priorities for July-December 2018
– Emerging and developed markets: provides information about key emerging and developed markets that are expected to offer significant growth over the next six months
– Change in M&A activity: analyzes healthcare industry executives’ opinions on changes in merger and acquisition activity globally
– Business concerns: identifies major business concerns that are likely to impact manufacturers and suppliers
– Average expenditure during the purchase: tracks the spending made during the purchase of different healthcare equipment
– Revenue contribution: evaluates what percentage of revenue contribution is made by different regions, healthcare equipment, and drug categories to global healthcare industry during 2017-2022
– Procurement budget outlook: projects procurement budget allocation in several healthcare areas in 2017 and how it is going to change over 2018
– Organizations’ digital transformation strategies and outlook: identifies executives’ perspectives towards the scope for, barriers to, and essentials of digital transformation within the healthcare industry
– Prevalence of emerging technology: determines the expected technology to gain investment among healthcare companies over the next two years

Scope

– Expansion in the current market, new product development, and improving operational efficiency are the top three priorities for the healthcare companies over the next six months

– Regulatory change and rising competition are projected to be the leading concerns for the healthcare industry during July-December 2018

– North America as a region and process equipment contributed the highest revenue to the global healthcare market in 2017 and are expected to remain the highest contributors during the next five years

– Overall, 61% of respondents anticipate an increase or significant increase in the number of mergers and acquisitions over the coming next six months

– The survey also reveals that the majority of healthcare organizations have a digital transformation strategy that they are actively pursuing.

Reasons to Buy

– The report highlights the key business priorities thus helping healthcare companies to realign their business strategy

– Helps enterprises by providing insights into the changes in procurement budget allocations and revenue contribution through projections anticipated by executives for July 2018-December 2018

– Assists healthcare companies to take informed decisions by providing information on the latest mergers and acquisitions within the market and by presenting executives’ views on the global M&A trend

– Gives analysis on global healthcare procurement budget expenditure and provides information on revenue contribution by different regions, healthcare equipment, and drug categories to the global healthcare industry during 2017-2022

– Realign digital transformation within your organization by identifying the scope for, challenges to, and essentials of digital transformation within the healthcare industry

– Additionally, it gives an understanding of key emerging and developed markets for the global healthcare industry – develop or adjust business expansion plans by gaining insights into the potential growth offering market.

Key Players

Takeda Pharmaceutical
GlaxoSmithKline Plc. (GSK)
Novartis International AG
Shire Plc

Table of Contents

Table of Contents

Introduction

Definitions

Methodology and sample size

Respondent profile

Global Business Outlook in June 2018-November 2018

Strategic business priorities

Emerging markets and developed markets with significant growth potential

Mergers and acquisition

Leading business concerns

Procurement Behaviors and Strategies

Typical average expenditure during the purchase of healthcare equipment in 2017

Procurement budget expenditure outlook in key areas for 2017 and 2018

Region-wise revenue contribution in global healthcare equipment market during 2017-2022

Revenue contribution in healthcare equipment categories on regional basis during 2017-2022

Revenue contribution in different drug categories on regional basis during 2017-2022

Digital Transformation and Emerging Technologies

Adoption of digital transformation strategy

Scope of digital transformation within healthcare industry

Barriers and essentials in digital transformation

Emerging technologies

Appendix

List of Figures

List of Figures

Figure 1: Organizations‘ Top Priorities – Overall (Jul 2018-Dec 2018)

Figure 2: Organizations‘ Top Five Priorities – By Region

Figure 3: Organizations‘ Top Five Priorities – By Company Types

Figure 4: Emerging and Developed Market with Significant Growth Opportunities – Overall (Jul 2018-Dec 2018)

Figure 5: Top Five Emerging Market with Significant Growth Opportunities – By Company Types

Figure 6: Top Five Developing Markets with Prominent Growth Prospects – By Company Types

Figure 7: Change in Mergers and Acquisitions – Overall (Jul 2018-Dec 2018)

Figure 8: Change in Mergers and Acquisitions – Regional

Figure 9: Change in Mergers and Acquisitions – By Company Types

Figure 10: Major Concerns for Organizations – Overall (Jul 2018-Dec 2018)

Figure 11: Top Five Major Concerns for Organizations – By Region

Figure 12: Top Five Major Concerns for Organizations – By Company Types

Figure 13: Average Expenditure During the Purchase of Healthcare Equipment in 2017 – Overall (Jul 2018-Dec 2018)

Figure 14: Procurement Budget Expenditure Outlook in Key Areas During 2017 and 2018 – Overall (Jul 2018-Dec 2018)

Figure 15: Region-Wise Revenue Contribution in Global Healthcare Equipment Market During 2017-2022 – Overall

Figure 16: Region-Wise Revenue Contribution in Global Healthcare Equipment Market During 2017-2022 – By Company Types

Figure 17: Revenue Contribution in Healthcare Equipment Categories on Regional Basis in 2017- Overall

Figure 18: Revenue Contribution in Healthcare Equipment Categories on Regional Basis in 2018- Overall

Figure 19: Revenue Contribution in Different Drug Categories on Regional Basis During 2017-2022 – Overall

Figure 20: Digital Transformation Strategy – Overall (Jul 2018-Dec 2018)

Figure 21: Digital Transformation Strategy – By Region

Figure 22: Digital Transformation Strategy – By Company Types

Figure 23: Scope of Digital Transformation – Overall (Jul 2018-Dec 2018)

Figure 24: Scope of Digital Transformation – By Region and Company Types

Figure 25: Barriers to Digital Transformation – Overall, Regional and Company Types (Jul 2018-Dec 2018)

Figure 26: Success Factors for Digital Transformation – Overall (Jul 2018-Dec 2018)

Figure 27: Success Factors for Digital Transformation – By Region

Figure 28: Success Factors for Digital Transformation – By Company Types

Figure 29: Emerging Technology – Overall (Jul 2018-Dec 2018)

Figure 30: Emerging Technology – By Region

Figure 31: Emerging Technology – By Company Types

$1,950

Can be used by individual purchaser only

$5,850

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Still undecided about purchasing this report?

Enquire Before Buying

Request a Free Sample

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods